Novorex Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$14M
- Investors
-
18
Novorex General Information
Description
Developer of a small-molecule therapeutics platform designed to discover treatments for neurological and immune-mediated diseases. The company offers artificial intelligence-driven molecular design, fragment-based drug discovery, structural biology, and biophysical validation using nuclear magnetic resonance, surface plasmon resonance, and X-ray crystallography, enabling pharmaceutical and biotechnology companies to identify drug candidates targeting challenging disease mechanisms, including Parkinson's disease and inflammatory disorders.
Contact Information
Website
www.novorex.comCorporate Office
- 240 Pangyoyeok-ro
- Bundang-gu
- Seongnam-si, Gyeonggi-do 13493
- South Korea
Corporate Office
- 240 Pangyoyeok-ro
- Bundang-gu
- Seongnam-si, Gyeonggi-do 13493
- South Korea
Novorex Timeline
Novorex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 09-Apr-2026 | $14M | Completed | Clinical Trials - Phase 1 | ||
| 5. Early Stage VC (Series A) | 20-Nov-2023 | Completed | Startup | |||
| 4. Early Stage VC (Series A) | 21-Jul-2021 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Mar-2020 | Completed | Startup | |||
| 2. Seed Round | 29-Feb-2020 | $1.34M | $1.34M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Novorex Comparisons
Industry
Financing
Details
Novorex Competitors (1)
One of Novorex’s competitors is Vernalis Therapeutics, a Corporation company based in Berwyn, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vernalis Therapeutics | Corporation | Berwyn, PA |
Novorex Patents
Novorex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025219272-A1 | Novel compounds as lrrk2 protein kinase domain inhibitors | Pending | 07-Feb-2024 | ||
| WO-2025170397-A1 | Novel compounds as lrrk2 protein kinase domain inhibitors | Pending | 07-Feb-2024 | ||
| WO-2024076155-A1 | Novel compound as yeats domain inhibitor | Inactive | 04-Oct-2022 |
Novorex Signals
Novorex Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hyundai Technology Investment | Venture Capital | Minority | ||
| K&N Investment Partners | Corporation | Minority | ||
| Korea Development Bank | PE/Buyout | Minority | ||
| SBI Investment | Venture Capital | Minority | ||
| Solidus Investment | Venture Capital | Minority |
Novorex FAQs
-
When was Novorex founded?
Novorex was founded in 2020.
-
Where is Novorex headquartered?
Novorex is headquartered in Seongnam-si, South Korea.
-
What is the size of Novorex?
Novorex has 33 total employees.
-
What industry is Novorex in?
Novorex’s primary industry is Drug Discovery.
-
Is Novorex a private or public company?
Novorex is a Private company.
-
What is the current valuation of Novorex?
The current valuation of Novorex is .
-
What is Novorex’s current revenue?
The current revenue for Novorex is .
-
How much funding has Novorex raised over time?
Novorex has raised $33.2M.
-
Who are Novorex’s investors?
Hyundai Technology Investment, K&N Investment Partners, Korea Development Bank, SBI Investment, and Solidus Investment are 5 of 18 investors who have invested in Novorex.
-
Who are Novorex’s competitors?
Vernalis Therapeutics is a competitor of Novorex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process